Oncology
1 drug is in development for Pancreatic Carcinoma.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Pancreatic Carcinoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| MGC028 | MACROGENICS INC (MGNX) |
About this indication
Pancreatic Carcinoma context
Oncology·MeSH: Pancreatic Neoplasms (D010190)
Narrower concept of MeSH descriptor Pancreatic Neoplasms
Frequently asked questions
How many drugs are in development for Pancreatic Carcinoma?
BioSniper tracks 1 drug in development for Pancreatic Carcinoma across 1 company.
How many clinical trials target Pancreatic Carcinoma?
There are 7 clinical trials targeting Pancreatic Carcinoma tracked by BioSniper.